Literature DB >> 21091930

Pathogenesis of alcoholic liver disease: interactions between parenchymal and non-parenchymal cells.

Jessica I Cohen1, Laura E Nagy.   

Abstract

The development of alcoholic liver disease (ALD) is a complex process involving both the parenchymal and non-parenchymal cells in the liver. The impact of ethanol on hepatocytes can be characterized as a condition of organelle stress with multifactorial changes in hepatocellular function accumulating during ethanol exposure. These changes include oxidative stress, mitochondrial dysfunction, decreased methylation capacity, endoplasmic reticulum stress, impaired vesicular trafficking and altered proteasome function. Injury to hepatocytes is attributed, in part, to ethanol metabolism by the hepatocytes. Changes in the structural integrity of hepatic sinusoidal endothelial cells, as well as enhanced inflammation in the liver during ethanol exposure are also important contributors to injury. Activation of hepatic stellate cells initiates the deposition of extracellular matrix proteins characteristic of fibrosis. Kupffer cells, the resident macrophages in the liver, are particularly critical to the onset of ethanol-induced liver injury. Chronic ethanol exposure sensitizes Kupffer cells to activation by lipopolysaccharides via toll-like receptor 4. This sensitization enhances the production of inflammatory mediators, such as tumor necrosis factor-α and reactive oxygen species that contribute to hepatocyte dysfunction, necrosis and apoptosis of hepatocytes and the generation of extracellular matrix proteins leading to fibrosis. In this review we provide an overview of the complex interactions between parenchymal and non-parenchymal cells in the liver during the progression of ethanol-induced liver injury.
© 2011 The Authors. Journal of Digestive Diseases © 2011 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21091930      PMCID: PMC5061145          DOI: 10.1111/j.1751-2980.2010.00468.x

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  81 in total

1.  Potentiation by chronic ethanol treatment of the mitochondrial permeability transition.

Authors:  J G Pastorino; A Marcineviciute; A Cahill; J B Hoek
Journal:  Biochem Biophys Res Commun       Date:  1999-11-19       Impact factor: 3.575

2.  Chronic ethanol consumption inhibits hepatic natural killer cell activity and accelerates murine cytomegalovirus-induced hepatitis.

Authors:  Hong-na Pan; Rui Sun; Barbara Jaruga; Feng Hong; Won-Ho Kim; Bin Gao
Journal:  Alcohol Clin Exp Res       Date:  2006-09       Impact factor: 3.455

Review 3.  Alcohol, host defence and society.

Authors:  Steve Nelson; Jay K Kolls
Journal:  Nat Rev Immunol       Date:  2002-03       Impact factor: 53.106

4.  Ethanol-induced alterations of the microtubule cytoskeleton in hepatocytes.

Authors:  Y Yoon; N Török; E Krueger; B Oswald; M A McNiven
Journal:  Am J Physiol       Date:  1998-04

5.  Effect of chronic alcohol consumption by rats on tumor necrosis factor-alpha and interleukin-6 clearance in vivo and by the isolated, perfused liver.

Authors:  I V Deaciuc; J M Alappat; K H McDonough; N B D'Souza
Journal:  Biochem Pharmacol       Date:  1996-09-27       Impact factor: 5.858

6.  Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.

Authors:  Y Iimuro; R M Gallucci; M I Luster; H Kono; R G Thurman
Journal:  Hepatology       Date:  1997-12       Impact factor: 17.425

7.  Hepatic fibrosis and cirrhosis after chronic administration of alcohol and "low-dose" carbon tetrachloride vapor in the rat.

Authors:  P D Hall; J L Plummer; A H Ilsley; M J Cousins
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425

8.  TLR4 enhances TGF-beta signaling and hepatic fibrosis.

Authors:  Ekihiro Seki; Samuele De Minicis; Christoph H Osterreicher; Johannes Kluwe; Yosuke Osawa; David A Brenner; Robert F Schwabe
Journal:  Nat Med       Date:  2007-10-21       Impact factor: 53.440

9.  Abrogation of the antifibrotic effects of natural killer cells/interferon-gamma contributes to alcohol acceleration of liver fibrosis.

Authors:  Won-Il Jeong; Ogyi Park; Bin Gao
Journal:  Gastroenterology       Date:  2007-09-29       Impact factor: 22.682

10.  Non-oxidative metabolism of ethanol by rat pancreatic acini.

Authors:  Paul S Haber; Minoti V Apte; Corey Moran; Tanya L Applegate; Romano C Pirola; Mark A Korsten; Geoffrey W McCaughan; Jeremy S Wilson
Journal:  Pancreatology       Date:  2004-03-30       Impact factor: 3.996

View more
  35 in total

Review 1.  Moderate ethanol ingestion and cardiovascular protection: from epidemiologic associations to cellular mechanisms.

Authors:  Maike Krenz; Ronald J Korthuis
Journal:  J Mol Cell Cardiol       Date:  2011-10-23       Impact factor: 5.000

Review 2.  Hepatic non-parenchymal cells: Master regulators of alcoholic liver disease?

Authors:  Wonhyo Seo; Won-Il Jeong
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

3.  Ceramide inhibitor myriocin restores insulin/insulin growth factor signaling for liver remodeling in experimental alcohol-related steatohepatitis.

Authors:  Diana Lizarazo; Valerie Zabala; Ming Tong; Lisa Longato; Suzanne M de la Monte
Journal:  J Gastroenterol Hepatol       Date:  2013-10       Impact factor: 4.029

4.  Therapeutic reversal of chronic alcohol-related steatohepatitis with the ceramide inhibitor myriocin.

Authors:  Ming Tong; Lisa Longato; Teresa Ramirez; Valerie Zabala; Jack R Wands; Suzanne M de la Monte
Journal:  Int J Exp Pathol       Date:  2013-10-29       Impact factor: 1.925

Review 5.  Role of alcohol in the development and progression of hepatocellular carcinoma.

Authors:  Iain H McKillop; Laura W Schrum; Kyle J Thompson
Journal:  Hepat Oncol       Date:  2015-11-30

6.  An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization.

Authors:  Jin-Kyu Park; Mingjie Shao; Moon Young Kim; Soon Koo Baik; Mee Yon Cho; Teruo Utsumi; Ayano Satoh; Xinsho Ouyang; Chuhan Chung; Yasuko Iwakiri
Journal:  Hepatology       Date:  2017-03-22       Impact factor: 17.425

7.  Effects of combined alcohol and anti-HIV drugs on cellular stress responses in primary hepatocytes and hepatic stellate and kupffer cells.

Authors:  Jay Hu; Hui Han; Mo Yin Lau; Harrison Lee; Michelle MacVeigh-Aloni; Cheng Ji
Journal:  Alcohol Clin Exp Res       Date:  2015-01       Impact factor: 3.455

8.  Insulin resistance, ceramide accumulation and endoplasmic reticulum stress in experimental chronic alcohol-induced steatohepatitis.

Authors:  Teresa Ramirez; Lisa Longato; Miroslav Dostalek; Ming Tong; Jack R Wands; Suzanne M de la Monte
Journal:  Alcohol Alcohol       Date:  2012-09-20       Impact factor: 2.826

9.  Cytokine profiling of exosomes derived from the plasma of HIV-infected alcohol drinkers and cigarette smokers.

Authors:  Sunitha Kodidela; Sabina Ranjit; Namita Sinha; Carole McArthur; Anil Kumar; Santosh Kumar
Journal:  PLoS One       Date:  2018-07-27       Impact factor: 3.240

10.  Ethanol targets nucleoredoxin/dishevelled interactions and stimulates phosphatidylinositol 4-phosphate production in vivo and in vitro.

Authors:  Jaime Arellanes-Robledo; Karina Reyes-Gordillo; Joseph Ibrahim; Leslie Leckey; Ruchi Shah; M Raj Lakshman
Journal:  Biochem Pharmacol       Date:  2018-08-18       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.